Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection

Transplant Infectious Disease

Volumn 12, Issue 3, 2010, Pages 269-272

  Lebeau, O ^a   Van Delden, C ^b,c   Garbino, J ^c   Robert, J ^a   Lamoth, F ^d   Passweg, J ^a   Chalandon, Y ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Transplant Division   (United States)

^c Division of Infectious Diseases   (United States)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Digestive graft versus host disease; Hematopoietic stem cell transplantation; Liposomal amphotericin B; Posaconazole; Rhizopus microsporus; Surgical resection; Zygomycetes; Zygomycosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CASPOFUNGIN; CYTARABINE; ETANERCEPT; IVERMECTIN; MELPHALAN; POSACONAZOLE; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE; AMPHOTERICIN B; ANTIFUNGAL AGENT; TRIAZOLE DERIVATIVE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENGRAFTMENT; FEMALE; FEVER; GASTROINTESTINAL DISEASE; HUMAN; HUMAN TISSUE; LOEFFLER PNEUMONIA; LUNG NODULE; MUSCLE RESECTION; NEPHRECTOMY; NEUTROPENIA; PRIORITY JOURNAL; RHIZOPUS; RHIZOPUS MICROSPORUS; SALVAGE THERAPY; SKIN DISEASE; STRONGYLOIDIASIS; SYSTEMIC MYCOSIS; TISSUE NECROSIS; ZYGOMYCOSIS; ALLOTRANSPLANTATION; CLASSIFICATION; COMPLICATION; DRUG COMBINATION; DRUG EFFECTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKEMIA, MYELOID, ACUTE; MICROBIOLOGY; MIDDLE AGED; MUCORMYCOSIS; TREATMENT OUTCOME;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MUCORMYCOSIS; RHIZOPUS; SALVAGE THERAPY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; TRIAZOLES;

EID: 77953227363     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00484.x     Document Type: Article

References (13)

1. Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004 39 : 743 746.
2. Rogers T. Treatment of zygomycosis: current and new options. J Antimicrob Chemother 2008 Jan 61 (Suppl 1) : i35 i40.
3. Kennedy GA, Butler J, Western R, Morton J, Durrant S, Hill GR. Combination antithymocyte globulin and soluble TNFalpha inhibitor (etanercept)+/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus host disease. Bone Marrow Transplant 2006 37 (12) : 1143 1147.
4. Pascual A, Rochat B, Pesse B, et al. Liquid chromatography tandem mass spectrometry (LC-MS/MS) and bioassay with extended analytical range for measurement of posaconazole plasma levels. 48th ICAAC/46th IDSA Annual Meeting, Washington, DC 2008, poster M-700.
5. Walsh TJ, Raad I, Patterson TF, et al. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis 2007 44 : 2 12.
6. Johnson MD, Perfect JR. Combination antifungal therapy: what can and should we expect? Bone Marrow Transplant 2007 40 : 297 306.
7. van Burik JA, Hare R, Solomon H, Corrado M, Kontoyiannis D. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006 42 : e61 e65.
8. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005 41 (5) : 634 653.
9. Uçkay I, Chalandon Y, Sartoretti P, et al. Invasive zygomycosis in transplant recipients. Clin Transplant 2007 21 (4) : 577 582.
10. Nosari A, Ravini M, Cairoli R, et al. Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia. Bone Marrow Transplant 2006 39 : 631 635.
11. Courtney R, Pai S, Laughlin M, Lim J, Batra V. Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults. Antimicrob Agents Chemother 2003 47 : 2788 2795.
12. Krishna G, Moton A, Ma L, Medlock MM, McLeod J. Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers. Antimicrob Agents Chemother 2009 53 : 958 966.
13. Dannaoui E, Meletiadis J, Mouton JW, Meis JFGM, Verweij PE, and the Eurofung Network. In vitro susceptibility of Zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003 51 : 45 52.